Detalhe da pesquisa
1.
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
N Engl J Med
; 378(18): 1671-1680, 2018 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29668352
2.
Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppression.
Br J Clin Pharmacol
; 87(2): 483-493, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32484940
3.
Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.
Respir Res
; 19(1): 19, 2018 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-29370819
4.
Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPD.
Pulm Pharmacol Ther
; 51: 59-64, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29981458
5.
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 196(4): 438-446, 2017 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28375647
6.
A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol.
Eur Respir J
; 48(2): 320-30, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27418551
7.
Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers.
Int J Clin Pharmacol Ther
; 53(9): 753-64, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26227101
8.
A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.
Pulm Pharmacol Ther
; 29(1): 49-57, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25020273
9.
Reply to Suissa and Ariel: The FULFIL Trial.
Am J Respir Crit Care Med
; 197(4): 542-543, 2018 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28950068
10.
Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 197(9): 1230-1231, 2018 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29241016
11.
Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease".
Am J Respir Crit Care Med
; 196(8): 1083-1084, 2017 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28534669
12.
Inhaled glucocorticoid-induced metabolome changes in asthma.
Eur J Endocrinol
; 187(3): 413-427, 2022 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35900313
13.
24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL Study.
Adv Ther
; 37(12): 4894-4909, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33011864
14.
Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life.
Adv Ther
; 35(1): 56-71, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29313286
15.
Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD.
J Clin Pharmacol
; 58(11): 1461-1467, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29762864
16.
Preventing clinically important deterioration with single-inhaler triple therapy in COPD.
ERJ Open Res
; 4(4)2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-30302335
17.
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses.
ERJ Open Res
; 4(2)2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-29750142
18.
Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial.
Adv Ther
; 34(9): 2163-2172, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28875459
19.
Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer.
J Aerosol Med Pulm Drug Deliv
; 29(4): 386-92, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26824933
20.
Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized study.
Int J Chron Obstruct Pulmon Dis
; 10: 15-23, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25565796